Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer : updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Bron
The lancet : international edition - ISSN 0140-6736-401:10371 (2023) p. 105-117
Auteur(s)
    Sara A. Hurvitz, Roberto Hegg, Wei-Pang Chung, Seock-Ah Im, William Jacot, Vinod Ganju, Joanne Wing Yan Chiu, Binghe Xu, Erika Hamilton, Srinivasan Madhusudan, Hiroji Iwata, Sevilay Altintas, Jan-Willem Henning, Giuseppe Curigliano, Jose Manuel Perez-Garcia, Sung-Bae Kim, Vanessa Petry, Chiun-Sheng Huang, Wei Li, Jean-Sebastien Frenel, Silvia Antolin, Winnie Yeo, Giampaolo Bianchini, Sherene Loi, Junji Tsurutani, Anton Egorov, Yali Liu, Jillian Cathcart, Shahid Ashfaque, Javier Cortes

Health-related quality of life in older patients with HER plus metastatic breast cancer : comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial

Bron
Journal of Geriatric Oncology - ISSN 1879-4068-13:5 (2022) p. 582-593
Auteur(s)
    Lissandra Dal Lago, Aime Lambert Uwimana, Corneel Coens, Peter Vuylsteke, Giuseppe Curigliano, Barbara Brouwers, Agnieszka Jagiello-Gruszfeld, Sevilay Altintas, Konstantinos Tryfonidis, Coralie Poncet, Andrew Bottomley, Berta Sousa, Etienne Brain, Hans Wildiers

Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer : a Belgian expert opinion

Bron
Facts, views & vision in obgyn : issues in obstetrics, gynaecology and reproductive health - ISSN 2032-0418-14:2 (2022) p. 111-120
Auteur(s)
    I. Vergote, H. Denys, Sevilay Altintas, J. Kerger, J-F Baurain, V. Bours, S. Henry, Koen Van de Vijver, D. Lambrechts, C. Gennigens

Evaluation of a supervised physical activity programme for cancer survivors : from treatment to triathlon

Bron
Journal of rehabilitation medicine : clinical communications - ISSN 2003-0711-3:1 (2020) p. 1-7
Auteur(s)